Prevention of gastroduodenal damage with omeprazolé in patients receiving continuous NSAIDs treatment. a double blind placebo controlled study

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 1, 1998, Pages 43-47

  Bianchi Porro, G ^a   Lazzaroni, M ^a   Petrillo, M ^a   Manzionna, G ^a   Montrone, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Nsaid gastropathy; Nsaids; Omeprazole

Indexed keywords

DICLOFENAC; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM INJURY; DYSPEPSIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STOMACH LESION; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DICLOFENAC; DOUBLE-BLIND METHOD; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; HUMANS; INDOMETHACIN; INTESTINAL MUCOSA; KETOPROFEN; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; RHEUMATIC DISEASES; SAFETY; TREATMENT OUTCOME;

EID: 0031944317     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Miller RR, Jick H. Acute toxicity of aspirin in hospitalized medical patients. Am J Med Sei 1977;274:271-9.
2. Dajani EZ, Agrawal NM. Protective effects of prostaglandins against non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. Int J Clin Pharm 1989:4:359-69.
3. Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J 1980:280:75-8.
4. Lanza FL, Royer GL. Nelson RS. A comparative endoscopie evaluation of the damaging effect of non steroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J Gastroenterol 1981:75:17-21.
5. Koch M, Capurso L, Dezi A, Ferrario F. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists. Dig Dis 1995;13(SuppI l):62-74.
6. Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory drug-induced gastroduoderial ulcération. New Ensl J Med 1992:327:1575-90.
7. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non steroidal antiinflammatory drugs. Ann Intern Med 1995:123:241-9.
8. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A. Double blind, placebo-controlled endoscopie comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1998;95:289-94.
9. Raskin JB, White JB, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Misoprostol and ranitidine in the prevention of NSAIDinduced ulcers: a prospective, double blind, multicentre study. Am J Gastroenterol 1996;91:223-7.
10. Taha AS, Hudson N, Hawkey CJ, Swannel AJ, Trye PN, Cottrel J, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. New Eng J Med 1996:334:1435-9.
11. Oddsson E, Gudjonsson H, Thjodleifsson B. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 1992;27:1045-8.
12. Dorta G, Saraga E, Nicolet M, Schnegg JF, Vouillamos D, Armstrong D, et al. Influence of omeprazole on healing and prevention of gastroduodenal mucosal lesions during administration of NSAIDs. Gastroenterology 1991;100:A95.
13. Ekstrom P, Carling S, Wetterhus S, Wingren PE, Ankerhansen O, Lundegardh G, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non steroidal anti-inflammatory drug therapy. Scand J Gastroenterol 1996:31:753-8.
14. Daneshmend TJ, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin induced gastric injury in man. Gut 1990:31:514-9.
15. Aadland E, Fausa O, Vatn M. Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med 1987;83(Suppl 1A): 37-40.
16. Somasundaram S, Hayllar H, Rafi S, Wriggleswoth JM, Macpherson AJS, Bjarnason I. The biochemical basis of nonsteroidal anti-inflammatory drug-induced damage to gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995:30:289-99.
17. Scheiman JM. Pathogenesis of gastroduodenal injury due to nonsteroidal antiinflammatory drugs: implications for prevention and therapy. Sem Arth Rheum 1992;21:201-10.
18. Lanza FL, Graham DY, Davis RE, Dack MF. Endoscopie comparison of cimetidine and sucralfate for prevention of naproxeninduced acute gastroduodenal injury. Effect of scoring method. Dig Dis Sei 1990:35:1494-9.
19. Bianchi Porro G, Lazzaroni M. Prevention and treatment of nonsteroidal gastroduodenal lesions. Eur J Gastroenterol Hepatol 1993;5:420-32.
20. Muller P, Leucht U, Simon B. High dose ranitidine protects completely stomach and duodenum against piroxicam. An endoscopie double blind pilot study. Z Gastroenterol 1992;30:851-3.
21. Cole AT, Brundell S, Hudson N, Hawthorn AB, Mahida YR, Hawkey CJ. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin. Aliment Pharmacol Ther 1992:6:707-15!
22. Ehsanullah RSB, Page MC, Tildesley G, Wood JR. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Br Med J 1988:297:1017-21.
23. French P, Darekar BS, Mills JG, Wood JR. Ranitidine in the prevention of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulcération in arthritic patients. Eur J Gastroenterol Hepatol 1994:6:1141-7.
24. Robinson MG. Griffin JW, Bowers J, Kogan FJ, Kogut DG, Lanza FL, et al. Effect of ranitidine on gastroduodenal mucosal damaae induced by nonsteroidal anti-inflammatory druas. Dia Dis Sei 1989;34(Suppl 3): 424-8.
25. Lee M, Kallal SM, Feldman M. Omeprazole prevents indomethacin-induced gastric ulcers in rabbits. Aliment Pharmacol Ther 1996; 10:571-6.
26. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, Van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drues. New Eng J Med 1998:338:719-26.
27. Hawkey CJ, Karrasch JA, Szczepanski L, Walker D, Barku A, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. New Eng J Med 1998:338:727-34.
28. Ivey KJ, Paone DB, Krause WJ. Acute effect of systemic aspirin on gastric mucosa in man. Dig Dis Sei 1980:25:97-9.
29. Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sei 1983;28:l-6.